{"denomUnitsSelected":"Participants","description":"The time elapsed for patients between initiation of study therapy and either disease progression or death","reportingStatus":"NOT_POSTED","timeFrame":"2 years after last dose of study drug","title":"Progression Free Survival","type":"SECONDARY"}